A novel cell signalling route was discovered by researchers at the Johns Hopkins Kimmel Cancer Centre that may one day be used as a therapeutic target for people with aggressive pancreatic cancer.
When people kiss, share drinks, or use the same eating utensils, the Epstein-Barr virus (EBV) primarily transmits through saliva. It should therefore come as no surprise that EBV is one of the most widespread viruses, affecting more than 90% of the population of world, primarily during child
The saliva is the main body fluid that the Epstein-Barr virus (EBV) spreads through when people kiss, share drinks or use the same dining utensils. So, it should come as no surprise that EBV is one of the most common viruses, infecting more than 90 per cent of the world's population, mostly
A team of researchers has uncovered how cancer evades the immune system and spreads throughout the body and is investigating ways to disable this potentially harmful trait.
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
According to new research, a biomarker signature can predict how well kidney cancer patients will respond to immunotherapy before treatment even starts. This biomarker signature is made up of the number of immune cells in and around kidney tumours, the volume of dead cancer tissue, and mutat
Researchers have made an AI-based diagnostic screening system called DeepGlioma that uses rapid imaging to analyze tumor specimens taken during an operation and detect genetic mutations more rapidly.
Researchers have developed an AI-based diagnostic screening system that uses rapid imaging to analyze tumor specimens taken during an operation and detect genetic mutations more rapidly
Personalization of cancer treatments has long been a goal--finding the right drugs that work for a patient's specific tumour based on specific genetic and molecular patterns. Many of these targeted therapies are highly effective, but they are not available for all cancers, including NSCLCs w